BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
BridgeBio Pharma, Inc. PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company ...